Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 314 record(s)

Req # A-2020-09098

Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
September 2020

Req # A-2020-001

Records dated February 2, 2020 to April 14, 2020 concerning coin minting operations during the COVID-19 outbreak, including extra costs on the handling of coins and distribution during the outbreak.

Organization: Royal Canadian Mint

25 page(s)
September 2020

Req # A-2020-002

Records dated January 7, 2020 to April 14, 2020 concerning plans and procedures in place regarding the production of new coins (circulation and numismatic) that would have a different effigy should Queen Elizabeth II be deceased, the replacement of any coins (circulation and numismatic) currently bearing the Queen’s image should Queen Elizabeth II be deceased, and estimates of the amount of each coin in circulation bearing her image.

Organization: Royal Canadian Mint

31 page(s)
September 2020

Req # A-2020-01436

Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

20 page(s)
August 2020

Req # A-2020-04137

Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

17 page(s)
August 2020

Nothing to report this month

Organization: Royal Canadian Mint

August 2020

Nothing to report this month

Organization: Royal Canadian Mint

July 2020

Req # A-2017-013

Provide any reports, discussion papers, decks, presentations, and/or briefing notes sent to the board of directors and/or the senior officers of the Mint regarding the previous change in the picture of the monarch on circulation coins from George VI to Elizabeth II and future changes to the picture of the monarch on all circulation coins.

Organization: Royal Canadian Mint

549 page(s)
June 2020

Req # A-2020-003

Briefing notes, memos, reports and cost benefits studies on ceasing the production of the five cent or ten cent coins, and costs associated with this change.

Organization: Royal Canadian Mint

0 page(s)
June 2020

Nothing to report this month

Organization: Royal Canadian Mint

May 2020
Date modified: